The Daily Abortion Goes to the Supreme Court (Again)
14 snips
Apr 19, 2023 
Adam Liptak, the Supreme Court correspondent for The New York Times, dives into the renewed abortion debate as the Court faces dueling rulings on abortion pills. He discusses a controversial ruling from a Texas judge questioning FDA approval and the implications it could have on drug accessibility. Liptak examines the complexities of the Supreme Court’s decision-making and the potential impacts of its conservative majority. With the abortion issue once again at the forefront, Liptak sheds light on the delicate balance of judicial reasoning in a politically charged atmosphere.
AI Snips
Chapters
Transcript
Episode notes
Abortion Returns to the Supreme Court
- The Supreme Court's overturning of Roe v. Wade signaled their intention to end their involvement in abortion-related issues.
- However, new rulings on abortion pills have brought the issue back to the court.
Targeting Mifepristone
- Anti-abortion groups targeted mifepristone, a common abortion pill, in states where abortion remained legal.
- They sued in Texas, arguing the FDA's approval of the drug in 2000 was based on flawed science.
Questionable Legal Standing
- The Texas judge's decision was criticized for several reasons, including the plaintiffs' questionable legal standing.
- Their claim of potential future harm from treating complications related to the pill was deemed too theoretical.